Back to Search
KATHLEEN ALDRICH, MD
MD
Hospitalist Physician
NPI: 1952755076IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
BP10056813(TX)85358(GA)2023-01349(NC)
Pediatrics Physician
Pediatrics
Code: 208000000X
BP10056813(TX)
Hospitalist PhysicianPrimary
Hospitalist
Code: 208M00000X
2023-01349(NC)
Education
UNIVERSITY OF TENNESSEE, HSC, COLLEGE OF MEDICINE
Class of 2016
Research & Publications (20)
What determines auditory similarity? The effect of stimulus group and methodology.
PMID 18609397·Q J Exp Psychol (Hove)·2009
8-other
Replicating adenovirus HIV/SIV recombinant priming alone or in combination with a gp140 protein boost results in significant control of viremia following a SHIV89.6P challenge in Mamu-A*01 negative rhesus macaques.
PMID 18252262·Virology·2008
7-preclinical
How to try this: define your terms. Evaluating instruments for use in nursing practice.
PMID 17895736·Am J Nurs·2007
8-other
A simplified method for the rapid fluorometric assessment of antibody-dependent cell-mediated cytotoxicity.
PMID 16343526·J Immunol Methods·2006
4-observational
Evaluation of passively transferred, nonneutralizing antibody-dependent cellular cytotoxicity-mediating IgG in protection of neonatal rhesus macaques against oral SIVmac251 challenge.
PMID 16951366·J Immunol·2006
7-preclinical
Enhanced immunity and protective efficacy against SIVmac251 intrarectal challenge following ad-SIV priming by multiple mucosal routes and gp120 boosting in MPL-SE.
PMID 15802969·Viral Immunol·2005
4-observational
Enhanced cellular immunity to SIV Gag following co-administration of adenoviruses encoding wild-type or mutant HIV Tat and SIV Gag.
PMID 16109434·Virology·2005
7-preclinical
Vaccine-elicited antibodies mediate antibody-dependent cellular cytotoxicity correlated with significantly reduced acute viremia in rhesus macaques challenged with SIVmac251.
PMID 15699150·J Immunol·2005
7-preclinical
Evaluation of combination DNA/replication-competent Ad-SIV recombinant immunization regimens in rhesus macaques.
PMID 15018712·AIDS Res Hum Retroviruses·2004
7-preclinical
Linguistic and location effects in compliance with pesticide warning labels for amateur and professional users.
PMID 15151153·Hum Factors·2004
4-observational
Designing trend-monitoring sounds for helicopters: methodological issues and an application.
PMID 15598119·J Exp Psychol Appl·2004
3-trial
Boosting of SIV-specific immune responses in rhesus macaques by repeated administration of Ad5hr-SIVenv/rev and Ad5hr-SIVgag recombinants.
PMID 12922139·Vaccine·2003
7-preclinical
Potent, persistent induction and modulation of cellular immune responses in rhesus macaques primed with Ad5hr-simian immunodeficiency virus (SIV) env/rev, gag, and/or nef vaccines and boosted with SIV gp120.
PMID 12885879·J Virol·2003
7-preclinical
Improved protection of rhesus macaques against intrarectal simian immunodeficiency virus SIV(mac251) challenge by a replication-competent Ad5hr-SIVenv/rev and Ad5hr-SIVgag recombinant priming/gp120 boosting regimen.
PMID 12857905·J Virol·2003
7-preclinical
A replication competent adenovirus 5 host range mutant-simian immunodeficiency virus (SIV) recombinant priming/subunit protein boosting vaccine regimen induces broad, persistent SIV-specific cellular immunity to dominant and subdominant epitopes in Mamu-A*01 rhesus macaques.
PMID 12682263·J Immunol·2003
7-preclinical
Hematological and blood viscosity changes in tail-suspended rats.
PMID 12137100·Aviat Space Environ Med·2002
7-preclinical
Effects of intestinal survival surgery on systemic and mucosal immune responses in SIV-infected rhesus macaques.
PMID 12519209·J Med Primatol·2002
4-observational
Comparison of erythrocyte osmotic fragility among ectotherms and endotherms at three temperatures.
PMID 11240223·J Therm Biol·2001
8-other
A conformational C4 peptide polymer vaccine coupled with live recombinant vector priming is immunogenic but does not protect against rectal SIV challenge.
PMID 11429125·AIDS Res Hum Retroviruses·2001
7-preclinical
Cross-protection in NYVAC-HIV-1-immunized/HIV-2-challenged but not in NYVAC-HIV-2-immunized/SHIV-challenged rhesus macaques.
PMID 11101054·AIDS·2000
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1364 CLIFTON RD NE
ATLANTA, GA 30322 - Phone
- (404) 778-5334
Quick Facts
- NPI
- 1952755076
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 5
- Locations
- 1
- Years in Practice
- 10
- Publications
- 20
Are you this provider?
Claim Your Profile